Tomoko Hirakawa

2PUBLICATIONS
0CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 20, 2017
Arcyriaflavin a, a cyclin D1-cyclin-dependent kinase4 inhibitor, induces apoptosis and inhibits proliferation of human endometriotic stromal cells: a potential therapeutic agent in endometriosis.

Tomoko Hirakawa, Kaei Nasu, Yoko Aoyagi

|Jul 19, 2017
Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402).

Tomoko Hirakawa, Takeo Minaguchi, Yoshio Itani

Pageof 1

Frequent Collaborators